Literature DB >> 9376367

Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts.

D K Nägler1, A C Storer, F C Portaro, E Carmona, L Juliano, R Ménard.   

Abstract

The main feature distinguishing cathepsin B from other cysteine proteases of the papain family is the presence of a large insertion loop, termed the occluding loop, which occupies the S' subsites of the enzyme. The loop is held in place mainly by two contacts with the rest of the enzyme, involving residues His110 and Arg116 on the loop that form salt bridges with Asp22 and Asp224, respectively. The influence of this loop on the endopeptidase activity of cathepsin B has been investigated using site-directed mutagenesis and internally quenched fluorogenic (IQF) substrates. Wild-type cathepsin B displays poor activity against the substrates Abz-AFRSAAQ-EDDnp and Abz-QVVAGA-EDDnp as compared to cathepsin L and papain. Appreciable increases in kcat/KM were observed for cathepsin B containing the single mutations D22A, H110A, R116A, and D224A. The highest activity however is observed for mutants where both loop to enzyme contacts are disrupted. For the triple-mutant D22A/H110A/R116A, an optimum kcat/KM value of 12 x 10(5) M-1 s-1 was obtained for hydrolysis of Abz-AFRSAAQ-EDDnp, which corresponds to a 600-fold increase relative to wild-type cathepsin B and approaches the level of activity observed with cathepsin L or papain. By comparison, the mutations have little effect on the hydrolysis of Cbz-FR-MCA. The influence of the mutations on the pH dependency of activity also indicates that the complexity of pH activity profiles normally observed for cathepsin B is related to the presence of the occluding loop. The major increase in endopeptidase activity is attributed to an increase in loop "flexibility" and suggests that the occluding loop might move when an endopeptidase substrate binds to the enzyme. The possible contribution of these interactions in regulating endopeptidase activity and the implications for cathepsin B activity in physiological or pathological conditions are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376367     DOI: 10.1021/bi971264+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Inhibition of mammalian cathepsins by Plesiomonas shigelloides.

Authors:  A Pavlova; K Krovácek; I Ciznár; C Gonzalez-Rey
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 5.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

6.  S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.

Authors:  Marcio F M Alves; Luciano Puzer; Simone S Cotrin; Maria Aparecida Juliano; Luiz Juliano; Dieter Brömme; Adriana K Carmona
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

7.  Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.

Authors:  J S Mort; M C Magny; E R Lee
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

8.  Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides.

Authors:  Maria Helena S Cezari; Luciano Puzer; Maria Aparecida Juliano; Adriana K Carmona; Luiz Juliano
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 9.  Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela R Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2012-08-16       Impact factor: 5.304

10.  Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.

Authors:  Iain D Kerr; Peng Wu; Rachael Marion-Tsukamaki; Zachary B Mackey; Linda S Brinen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.